

Mondelez vs Kimberly-Clark
Global snacks and confectionery leader with strong brands vs Global maker of tissue and personal care products. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
Mondelez International sells snacks, cookies, and chocolate under beloved brands like Oreo, Cadbury, and Toblerone to consumers in over 150 countries, using pricing power and emerging market growth to drive earnings, while Kimberly-Clark produces tissue, diapers, and personal care products that consumers replenish out of necessity rather than indulgence. Both companies are classic consumer staples compounders, using global distribution and brand loyalty to pass through cost inflation and generate reliable cash flows. The Mondelez vs Kimberly-Clark comparison examines how a snacking powerhouse and a tissue and hygiene giant compare on organic growth, pricing dynamics, and capital return strategies.
Mondelez International sells snacks, cookies, and chocolate under beloved brands like Oreo, Cadbury, and Toblerone to consumers in over 150 countries, using pricing power and emerging market growth to...
Why It’s Moving

Mondelez is drawing a split but still supportive analyst read as cost pressure weighs on the outlook.
- Analysts have stayed broadly constructive on Mondelez, with consensus estimates still clustered around a mid-to-high $60s valuation range, suggesting the market sees the stock as fairly stable rather than a high-growth name.
- Recent target changes have been mixed: some firms trimmed their outlook on cautious consumer-staples assumptions and cocoa-cost pressure, while others kept outperform-style ratings, signaling confidence in Mondelez’s resilience.
- The biggest takeaway for investors is that the debate is less about near-term demand and more about margin pressure, input costs, and how much pricing power Mondelez can sustain in a softer macro backdrop.

KMB’s upside case hinges on whether cost cuts can outweigh softer sales and margin pressure.
- Analysts are still pointing to mixed momentum: softer North America sales and cost pressure are weighing on the near-term setup, even as investors watch for benefits from ongoing portfolio cleanup and efficiency efforts.
- The stock is being framed around a broader improvement story, with analysts focusing on whether divestitures and cost synergies can offset weak category trends and input-cost uncertainty.
- Recent analyst views remain mostly cautious, which makes any upside case depend less on a single catalyst and more on evidence that margin discipline and business transformation are starting to show through.

Mondelez is drawing a split but still supportive analyst read as cost pressure weighs on the outlook.
- Analysts have stayed broadly constructive on Mondelez, with consensus estimates still clustered around a mid-to-high $60s valuation range, suggesting the market sees the stock as fairly stable rather than a high-growth name.
- Recent target changes have been mixed: some firms trimmed their outlook on cautious consumer-staples assumptions and cocoa-cost pressure, while others kept outperform-style ratings, signaling confidence in Mondelez’s resilience.
- The biggest takeaway for investors is that the debate is less about near-term demand and more about margin pressure, input costs, and how much pricing power Mondelez can sustain in a softer macro backdrop.

KMB’s upside case hinges on whether cost cuts can outweigh softer sales and margin pressure.
- Analysts are still pointing to mixed momentum: softer North America sales and cost pressure are weighing on the near-term setup, even as investors watch for benefits from ongoing portfolio cleanup and efficiency efforts.
- The stock is being framed around a broader improvement story, with analysts focusing on whether divestitures and cost synergies can offset weak category trends and input-cost uncertainty.
- Recent analyst views remain mostly cautious, which makes any upside case depend less on a single catalyst and more on evidence that margin discipline and business transformation are starting to show through.
Investment Analysis

Mondelez
MDLZ
Pros
- Mondelez has a strong global brand portfolio including Oreo, Ritz, and CLIF Bar, supporting resilient top-line growth across diverse markets.
- The company showed an adjusted EPS beat in Q3 2025 despite inflationary cost pressures, indicating operational profitability resilience.
- Recent market valuation metrics suggest Mondelez is undervalued by about 64.6% based on discounted cash flow analysis, signaling potential long-term value.
Considerations
- Mondelez's Q3 2025 revenue missed analyst expectations, leading to a negative investor reaction and stock price decline.
- High cocoa costs have significantly impacted margins and represent a primary inflation-related challenge for the company’s snack segments.
- The stock experienced a notable decline of approximately 14.6% over the past year, reflecting market concerns over growth prospects and margin sustainability.
Pros
- Kimberly-Clark benefits from a strong and diversified portfolio in personal care products with significant market presence in North America and internationally.
- The company maintains robust financial metrics including a net income of approximately $1.97 billion and a dividend yield near 5%, supporting income investors.
- Kimberly-Clark's stock trades at a forward P/E of about 13.08, indicating relatively attractive valuation compared to industry peers.
Considerations
- The stock has experienced a constrained 52-week trading range with limited upside momentum after peaks near $150, now trading closer to $100.
- Kimberly-Clark faces competitive and cost pressures in personal care and tissue markets that may affect margin expansion.
- Beta of 0.25 indicates low volatility, which may limit gains during strong market rallies for investors seeking growth.
Mondelez (MDLZ) Next Earnings Date
MDLZ’s next earnings release is expected on July 28, 2026, based on the company’s usual late-July reporting pattern. The report should cover Q2 2026. Some sources still show a wider estimate window of July 28–31, 2026 if the company has not formally confirmed the date.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings release is typically expected in late July to early August 2026, with current estimates clustering around July 28, 2026 to August 7, 2026. The report will cover Q2 2026 results, based on the company’s quarterly reporting cycle following its Q1 2026 release in late April. If the company has not formally confirmed a date, the most defensible expectation is an announcement in the final week of July or first week of August.
Mondelez (MDLZ) Next Earnings Date
MDLZ’s next earnings release is expected on July 28, 2026, based on the company’s usual late-July reporting pattern. The report should cover Q2 2026. Some sources still show a wider estimate window of July 28–31, 2026 if the company has not formally confirmed the date.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings release is typically expected in late July to early August 2026, with current estimates clustering around July 28, 2026 to August 7, 2026. The report will cover Q2 2026 results, based on the company’s quarterly reporting cycle following its Q1 2026 release in late April. If the company has not formally confirmed a date, the most defensible expectation is an announcement in the final week of July or first week of August.
Buy MDLZ or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


